Evidence map›Paper›PMID 34983384›Full record

ArticleBMC microbiology2022

Urogenital Microbiota:Potentially Important Determinant of PD-L1 Expression in Male Patients with Non-muscle Invasive Bladder Cancer.

Chunxiao Chen, Zehai Huang, Pengcheng Huang, Kun Li, Jiarong Zeng, Yuehui Wen, Biao Li, Jie Zhao, Peng Wu

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. The emerging role of the microbiome in bladder cancer: prognostic implications and treatment response.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas · 2026
    Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. The Urinary Microbiome in Health and Disease: Relevance for Bladder Cancer.International journal of molecular sciences · 2024
    Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Research progress on the microbiota in bladder cancer tumors.Frontiers in cellular and infection microbiology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Chunxiao Chen *Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Zehai Huang *Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Pengcheng HuangDepartment of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Kun LiThe third hospital of mianyang, Sichuan Province, China.
Jiarong ZengDepartment of Urology, Meizhou People's Hospital, Meizhou, China.
Yuehui WenMeizhou hospital of TCM, Meizhou, China.
Biao LiDepartment of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Jie ZhaoSchool of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China. zhaojie_0412@163.com.
Peng WuDepartment of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China. doctorwupeng@gmail.com.
Nanfang Hospital · CNSouthern Medical University · CNMeizhou City People's Hospital · CNMianyang Third People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUrogenital microbiota may be associated with the recurrence of bladder cancer, but the underlying mechanism remains unclear. The notion that microbiota can upregulate PD-L1 expression in certain epithelial tumors to promote immune escape has been demonstrated. Thus, we hypothesized that the urogenital microbiota may be involved in the recurrence and progression of non-muscle invasive bladder cancer (NMIBC) by upregulating the PD-L1 expression. To test this hypothesis, we investigated the relationship between urogenital microbial community and PD-L1 expression in male patients with NMIBC.

results16S rRNA gene sequencing was performed to analyse the composition of urogenital microbiota, and the expression of PD-L1 in cancerous tissues was detected by immunohistochemistry. The subjects (aged 43-79 years) were divided into PD-L1-positive group (Group P, n = 9) and PD-L1-negative group (Group N, n = 19) respectively based on their PD-L1 immunohistochemical results. No statistically significant differences were found in the demographic characteristics between group P and N. We observed that group P exhibited higher species richness (based on Observed species and Ace index, both P < 0.05). Furthermore, subgroup analysis showed that the increase in number of PD-L1 positive cells was accompanied by increased richness of urogenital microbiota. Significantly different composition of urogenital microbiota was found between group P and group N (based on weighted Unifrac and unweighted Unifrac distances metric, both P < 0.05). Enrichment of some bacterial genera (e.g., Leptotrichia, Roseomonas, and Propionibacterium) and decrease of some bacterial genera (e.g., Prevotella and Massilia) were observed in group P as compared with group N. These findings indicated that these genera may affect the expression of PD-L1 through some mechanisms to be studied.

conclusionOur study provided for the first time an overview of the association between urogenital microbiota and PD-L1 expression in male patients with NMIBC, indicating that urogenital microbiota was an important determinant of PD-L1 expression in male NMIBC patients.

Indexed as

MicrobiotaAdultAgedB7-H1 AntigenBacteriaDisease ProgressionHumansMaleMiddle AgedRecurrenceUrinary Bladder NeoplasmsUrogenital SystemB7-H1 AntigenCD274 protein, humanBladder cancerImmune escapeMicrobiotaPD-L1Urogenital tract

Identifiers

PMID34983384
PMCPMC8725255
OpenAlexW4205726745

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.